Andis Robeznieks is a Senior Communications Specialist at a leading healthcare organization. He reports on public health, healthcare administration, digital health, and physician advocacy, with a keen interest in healthcare construction and design. His work has been featured in NewsBreak and the American Medical Association.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Andis Robeznieks' coverage primarily revolves around healthcare and pharmaceuticals, with a focus on government announcements and data citations. Based on this information, experts who can provide insights into the impact of government policies on healthcare, particularly in relation to telehealth, Medicare, physician burnout, health equity and broader health policy issues are likely to gain his attention.
Given Andis’ reliance on data citations and exclusive sources for his articles, he may be interested in engaging with experts who have access to relevant healthcare data or those involved in shaping governmental policies within the healthcare sector.
Furthermore, considering that there is no specific geographic focus mentioned for Andis’s articles it is likely that he covers topics with a global perspective.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Andis Robeznieks
With data and commitment, value-based care payment models can help sustain larger physician-led organizations and smaller private practices.
By: Andis Robeznieks
After surviving a brain tumor, AMA President Bobby Mukkamala, MD, has been on a “journey of revelation” about the U.S. health system.
By: Andis Robeznieks
The Drug Enforcement Administration and the Centers for Medicare & Medicaid Services tell doctors not to respond to suspicious requests for information.
By: Andis Robeznieks
The AMA’s educational content on CPT helps build coding proficiency and facilitate reliable communication for patient care.
What’s the news: An updated AMA analysis indicates that little competition exists among pharmacy benefit managers (PBMs). Local PBM markets are on average highly concentrated—as defined by the U.S. Department of Justice (DOJ) and the Federal Trade Commission (FTC)—which suggests low competition among these pharmaceutical supply-chain middlemen.
Mastering the basics on the business of medicine is a vital first step to boost your skillset, and the AMA has the CME to help you do it.
The Drug Enforcement Administration and the Centers for Medicare & Medicaid Services tell doctors not to respond to suspicious requests for information.
Andis retired from the AMA after serving as a senior news writer from 2017 to 2025. That tenure followed an earlier stint with the AMA as a reporter on health care quality, medical ethics and patient safety topics for American Medical News.
Mastering the basics on the business of medicine is a vital first step to boost your skillset, and the AMA has the CME to help you do it.
